Target Biotech ApS: Financial statements 2023
CVR: 39676478
Source: annual report 2023, Danish Business Authority
01/01/2023 – 31/12/2023
Target Biotech ApS (CVR 39676478) has filed annual accounts for 2023. In 2023, the company reported a gross profit of DKK 63,828 and a net result of DKK 3,926 compared with DKK 56,725 the year before. That is a decrease of 84.2% compared with the year before. Equity in the 2023 report amounted to DKK 332,792. The solvency ratio was 68.6%. The company had 1 employee in the financial year.
- Gross Profit
- DKK 63,828
- Profit/Loss
- DKK 3,926
- Equity
- DKK 332,792
- Total Assets
- DKK 484,952
- Employees
- 1
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2023 | - | 64 t. | 4 t. | 333 t. | 1 |
| 2022 | - | 403 t. | 57 t. | 329 t. | 1 |
| 2021 | - | 487 t. | 88 t. | 272 t. | 1 |
| 2020 | - | 365 t. | 24 t. | 184 t. | 1 |
| 2019 | - | 221 t. | 57 t. | 160 t. | 1 |
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record — straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2023
Target Biotech ApS has published its annual report for 2022. Gross profit came to DKK 402,821, and the net result was DKK 56,725.
About Target Biotech ApS
Target Biotech ApS is a Danish company of the type Anpartsselskab based in Allerød, founded in 2018. The company is registered under the industry Virksomhedsrådgivning og anden ledelsesrådgivning. The management consists of Peter Horn Møller. The company is owned by Peter Horn Møller. The company has 0 employees (2018). In 2025, the company reported a gross profit of DKK -19,344 and a net result of DKK -7,028,421 compared with DKK 23,952,623 the year before. Equity in the 2025 report amounted to DKK 10,735,912.